Log in

View Full Version : NeoPharm Presents The Phase II Data Of Liposome-Entrapped Paclitaxel (LEP) In Patient

News
01-08-2010, 05:12 AM
NeoPharm, Inc. (Other OTC: NEOL.PK) announced the results of a Phase II clinical trial of Liposome-Entrapped Paclitaxel (LEP) an active component of Taxol®. This multicenter, open-label trial of LEP was conducted at 5 centers in India...

More... (http://mnt.to/f/3w4c)